THTX — Theratechnologies Balance Sheet
0.000.00%
- $147.42m
- $181.12m
- $85.87m
- 39
- 71
- 77
- 67
Annual balance sheet for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 20.8 | 40.4 | 33.1 | 40.4 | 9.62 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13.2 | 10.9 | 12.3 | 13.6 | 15.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 64.8 | 91.9 | 73.4 | 63.3 | 44 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.48 | 2.85 | 3.09 | 1.98 | 1.26 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 100 | 119 | 93.3 | 77.8 | 53.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 41.9 | 45.1 | 114 | 47.3 | 36.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 96.9 | 101 | 116 | 98.6 | 78.6 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3.22 | 17.8 | -22.6 | -20.9 | -25.3 |
| Total Liabilities & Shareholders' Equity | 100 | 119 | 93.3 | 77.8 | 53.3 |
| Total Common Shares Outstanding |